Publication: Triptolide inhibits tonsillar IgA production by upregulating FDC-SP in IgA nephropathy
Authors
Li, Huining ; Yang, Xinxin ; Yao, Guodong ; Zhang, Yanxiang ; Xu, Yangyang ; Cao, Yan ; An, Xushu ; Li, Haibo ; Chen, Hui ; Geng, Jingshu ; Yuan, Dawei ; Jin, Xiaoming ; Meng, Hongxue
item.page.secondaryauthor
item.page.director
Publisher
Universidad de Murcia, Departamento de Biologia Celular e Histiologia
publication.page.editor
publication.page.department
DOI
https://doi.org/10.14670/HH-18-190
item.page.type
info:eu-repo/semantics/article
Description
Abstract
IgA nephropathy (IgAN) is primarily
resulted of qualitative abnormality of IgA. The
occurrence of IgAN is associated with affected tonsils
which enhances the IgA production via IgA class
switching and immuno-activation. Follicular dendritic
cell-secreted protein (FDC-SP) was found to be a
negative effect for IgA production in tonsil. The previous
studies suggested that Triptolide might reduce IgA
production by its immunosuppression role. Given this
background, this study investigated the mechanisms
underlying the role of Triptolide and FDC-SP in the
generation of IgA and IgA class switching in tonsil of
IgAN patients. Immunohistochemistry and reverse
transcription-polymerase chain reaction revealed that the
expression of FDC-SP was increased in the tonsils of
IgAN patients with Triptolide treatment compared with
those without treatment. Meanwhile, the expression of
FDC-SP was negatively correlated with IgA inducing
cytokines in the tonsils of IgAN patients treated with
Triptolide, due to the significant decreased IgA-bearing
cells. The expression of FDC-SP in tonsillar tissue was
confirmed by double immunofluorescence. Importantly,
Triptolide promoted FDC-SP secretion, and correlated
negatively with decreased IgA production in isolated
FDC-associated clusters, which had been isolated from
patients without TW treatment previously. Our study
demonstrated that Triptolide might have an impact on
FDC-SP production and downregulation of IgA
synthesis in the tonsils of IgAN patients, which could be
a promising strategy for therapeutic intervention in
IgAN patients.
publication.page.subject
Citation
Histology and Histopathology Vol. 35, nº6 (2020)
item.page.embargo
Ir a EstadÃsticas
Este Ãtem está sujeto a una licencia Creative Commons. http://creativecommons.org/licenses/by-nc-nd/4.0/